Compare Corning Incorporated (GLW) vs Globus Medical Inc. Class A Common Stock (GMED) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Corning Incorporated vs Globus Medical Inc. Class A Common Stock — how do they compare? Corning Incorporated trades at $135.72 (market cap $121.36B), while Globus Medical Inc. Class A Common Stock trades at $76.58 (market cap $10.25B). The key difference: Corning Incorporated is far larger — about 11.8× Globus Medical Inc. Class A Common Stock's market cap, and Corning Incorporated pays a 0.79% dividend while Globus Medical Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Corning Incorporated for 36 Days and Globus Medical Inc. Class A Common Stock for 0 Days on average.
| GLW | GMED | |
|---|---|---|
Market Cap | $121.36B | $10.25B |
Volume | 7,874,233 | 1,059,528 |
Sector | Technology | Health |
52-Week High | $255.79 | $96.82 |
52-Week Low | $78.03 | $58.33 |
Typical Hold Time | 36 Days | 0 Days |
Enterprise Value | $128.24B | $9.76B |
Dividend Yield | 0.79% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Corning (GLW) trades at $148.52, up 0.87% with recent earnings beats and a major $3B AT&T fiber deal driving optimism. Technical indicators show bearish momentum with support at $144 and resistance at $153. The company demonstrates strong fundamental improvement with 2025 revenue reaching $15.63B and net income surging to $1.60B, though valuation multiples remain elevated with a P/E of 68.45.
GLW presents growth potential through AI infrastructure demand and fiber expansion, supported by 57% analyst buy ratings and a $171.25 price target. Key risks include patent litigation investigations and high valuation sensitivity to earnings growth. The stock offers 15% upside to consensus target but requires monitoring of legal developments and margin sustainability.
Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.
GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Corning Incorporated
Corning Inc is a leader in materials science, specializing in the production of glass, ceramics and optical fiber. The firm supplies its products for a wide range of applications, from flat-panel displays in televisions to gasoline particulate filters in automobiles to optical fiber for broadband access, with a leading share in many of its end markets.
Read more on GLW →About Globus Medical Inc. Class A Common Stock
Globus Medical, Inc. develops and manufactures medical devices for treating musculoskeletal disorders, including spine, orthopedic trauma, and neurosurgical products. It operates in US and internationally, serving surgeons and healthcare providers.
Read more on GMED →
